Abstract:Introduction: Cytokines are important elements of the tumor microenvironment (TME) coordinating host responses against the tumor, promoting growth, invasion, angiogenesis and regulating non-tumoral cells in TME. Little is known regarding the cytokine network in pituitary adenomas (PAs) and its role in the TME. We aimed to characterise PA-derived cytokines to study their role in the TME of PAs. Methods: The cytokine secretome of culture supernatants from 27 human PAs (16 NFPAs, 9 GHomas, 1 TSHoma, 1 ACTHoma) was assessed using Millipore MILLIPLEX cytokine/chemokine 42-plex. IL-8 and CCL2 expression was further studied by RNAscope. Angiogenesis, macrophages and epithelial-to-mesenchymal transition were evaluated by immunohistochemistry for CD31, CD68, CD163, HLA-DR, E-cadherin and ZEB1. Macrophage infiltration in PAs and its phenotype was further assessed with the gene-signature based method xCELL. We have developed an in vitro model of pituitary cells (GH3) and macrophages (RAW264.7) and studied their interaction via assessing the effect of conditioned media. We documented cell morphology (ImageJ), migration and invasion (Boyden chambers), epithelial-to-mesenchymal transition pathway (RT-qPCR and immunocytochemistry) and secretome changes (cytokine array). Results: IL-8, CCL2, CCL3 and CCL4 are the main PA-derived cytokines, with CXCL1, CXCL10, CCL22 and CX3CL1 also secreted by most of these tumors. RNAscope data showed that CCL2 and IL-8 are mainly synthesised in the pituitary tumour cells. NFPAs secreted more cytokines than somatotropinomas, especially CCL2 (16x more), IL-8 (25x more) and CCL4 (27x more). PAs contained more macrophages than normal pituitary (4.9±0.7 vs 1.2±0.2%, p=0.007). Macrophage infiltration was associated with higher chemokine levels (CCL2, CCL3, CCL4, CXCL1 and IL-8). Macrophages in PAs belong to the CD163+ M2-subtype, while in normal pituitary M1-macrophages predominate, resulting in 3-fold increased M2:M1 ratio in PAs (p<0.001). These findings were confirmed with xCELL on a different set of PA samples. M2:M1 ratio correlated with microvessel density (r=0.509; p=0.008). Macrophage-conditioned media induced numerous effects on GH3 cells: more elongated, epithelial-to-mesenchymal transition-like cells, significantly increased migration and invasiveness, and altered GH3 cell cytokine secretome. On other hand, GH3 cell-conditioned media induced activation-associated morphological changes in RAW264.7 macrophages, increased chemotaxis and altered macrophage cytokine secretome. Conclusions: Primarily M2-subtype macrophages are present in the TME of PAs and their number is correlating with CCL2, IL-8, CCL3 and CCL4 release. NFPAs secrete higher levels of cytokines than somatotropinomas. Our data suggest that there is crosstalk between pituitary tumor cells and macrophages which may determine the biological behavior of PAs.

Untargeted lipidomics reveals specific lipid abnormality in nonfunctioning human pituitary adenomas.

Serum Metabolites Differentiate Amnestic Mild Cognitive Impairment From Healthy Controls And Predict Early Alzheimer'S Disease Via Untargeted Lipidomics Analysis

Proteomic and Functional Profiles of a Follicle‐stimulating Hormone Positive Human Nonfunctional Pituitary Adenoma

Heterogeneity Analysis of the Proteomes in Clinically Nonfunctional Pituitary Adenomas

Multiomics-Based Signaling Pathway Network Alterations in Human Non-functional Pituitary Adenomas

Human Pituitary Adenoma Proteomics: New Progresses And Perspectives

Strategy for Identifying a Robust Metabolomic Signature Reveals the Altered Lipid Metabolism in Pituitary Adenoma.

Enhanced EPR Effects by Tumour Stromal Cell Mimicking Nanoplatform on Invasive Pituitary Adenoma

Quantitative Analysis of Proteome in Non-functional Pituitary Adenomas: Clinical Relevance and Potential Benefits for the Patients

Identification of the Proteomic Variations of Invasive Relative to Non-Invasive Non-Functional Pituitary Adenomas.

Metabolic Characteristics and M2 Macrophage Infiltrates in Invasive Nonfunctioning Pituitary Adenomas

Expression of cAMP and oxidative phosphorylation‐related lncRNAs in non‐functioning pituitary adenomas

Metabolomics Profiling of Pituitary Adenomas by Raman Spectroscopy, Attenuated Total Reflection-Fourier Transform Infrared Spectroscopy, and Mass Spectrometry of Serum Samples.

Integrated multi-omics profiling of nonfunctioning pituitary adenomas

Quantitative global lipidomics analysis of patients with ovarian cancer versus benign adnexal mass

Morpho-Molecular Metabolic Analysis and Classification of Human Pituitary Gland and Adenoma Biopsies Based on Multimodal Optical Imaging

Association between Intracellular Calcium Signaling and Tumor Recurrence in Human Non-Functioning Pituitary Adenomas

Novel Biomarkers for Non-functioning Invasive Pituitary Adenomas Were Identified by Using Analysis of Micrornas Expression Profile

MON-462 Cytokine Network in Pituitary Adenomas and Its Role in the Tumor Microenvironment: Focus on Macrophages

Exosomal miRNA Profiling is a Potential Screening Route for Non-Functional Pituitary Adenoma

Methylome Analysis in Nonfunctioning and GH-Secreting Pituitary Adenomas